Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

MedinCell

Biotech & Life Sciences · Jacou, France · Founded 2002 · IPO 2018 Colt

Develops therapeutic solutions based on proprietary copolymers and a biocompatible solvent

Valuation
$980M
Market cap · May/2026
Revenue
$28M
Latest reported FY

Investors

4 investors on MedinCell's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 4 investors entered at this stage
Crédit Mutuel Innovation
HEC Paris
Crédit Mutuel Equity
HEC Challenge+

Global footprint

Where MedinCell has talent and traffic

AI talent share
0.6% of workforce is AI talent
(1 of 177 staff)
Core AI10.56%
Other AI00%
Non-AI workforce17699.44%
Workforce by country
🇫🇷 France · Jacou HQ
Book a demo for the full country breakdown
Web traffic by country
11K monthly visits
across markets
🇫🇷 France73.6%
🇺🇸 United States20%
🇳🇱 Netherlands5.5%
Top 3 markets shown

Market sentiment

What the market is saying about MedinCell

An AI-synthesized read of the highest-engagement posts about MedinCell on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See MedinCell on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.